Medclair Invest AB Share Price

Equities

MCLR

SE0009190572

Industrial Machinery & Equipment

End-of-day quote NORDIC GROWTH MARKET 23:00:00 28/04/2024 BST 5-day change 1st Jan Change
1.25 SEK +0.81% Intraday chart for Medclair Invest AB +2.46% -25.51%

Financials

Sales 2021 13.32M 1.22M 97.08M Sales 2022 28.17M 2.58M 205M Capitalization 103M 9.4M 748M
Net income 2021 -13M -1.19M -94.77M Net income 2022 -5M -458K -36.45M EV / Sales 2021 15.2 x
Net cash position 2021 18.84M 1.73M 137M Net cash position 2022 3M 275K 21.91M EV / Sales 2022 3.54 x
P/E ratio 2021
-16.8 x
P/E ratio 2022
-20.7 x
Employees 12
Yield 2021 *
-
Yield 2022
-
Free-Float 9.89%
More Fundamentals * Assessed data
Dynamic Chart
Medclair Invest AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Medclair Invest AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Medclair Invest AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Medclair Invest AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 CI
Medclair Invest AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Medclair Invest AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Medclair Invest AB Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Medclair Invest AB Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Medclair Invest AB Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Medclair Invest AB cancelled the acquisition of NoseOption AB. CI
Medclair Invest AB agreed to acquire NoseOption AB for SEK 48.8 million. CI
MedClair International AB completed the acquisition of Spintso International AB in a reverse merger transaction. CI
MedClair International AB agreed to acquire Spintso International AB in a reverse merger transaction for SEK 20 million. CI
MedClair AB completed the acquisition of US Energy Group AB (XSAT:USE B) from Anders Lagerberg and other shareholders in a reverse merger transaction. CI
MedClair AB agreed to acquire US Energy Group AB (XSAT:USE B) from Anders Lagerberg and other shareholders in a reverse merger transaction. CI
More news
1 day+0.81%
1 week+2.46%
Current month-1.57%
1 month-1.57%
3 months-17.87%
6 months-15.65%
Current year-25.51%
More quotes
1 week
1.21
Extreme 1.205
1.30
1 month
1.19
Extreme 1.185
1.30
Current year
1.19
Extreme 1.185
1.68
1 year
1.10
Extreme 1.104
1.76
3 years
1.10
Extreme 1.104
3.46
5 years
0.85
Extreme 0.85
3.46
10 years
0.85
Extreme 0.85
3.46
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 31/12/18
Members of the board TitleAgeSince
Director/Board Member 48 31/12/09
Chairman - 31/12/20
Director/Board Member 57 31/12/19
More insiders
Date Price Change Volume
29/04/24 1.25 +0.81% 28,013
26/04/24 1.24 -4.25% 101,594
25/04/24 1.295 +5.28% 68,753
24/04/24 1.23 +2.07% 136,115
23/04/24 1.205 -0.82% 93,549

End-of-day quote NORDIC GROWTH MARKET, April 28, 2024

More quotes
Medclair Invest AB is a Sweden-based research and development company engaged in the measurement, collection and destruction of Nitrous Oxide (N2O). The Company works on process gas purification, gas measurement, ventilation, and control and specialized in catalytic gas purification. The Company’s customers are mainly in healthcare areas that require a climate-smart use of Nitrous Oxide for pain relief such as Maternity wards, Children’s healthcare facilities and Dental care facilities.
More about the company

Annual profits - Rate of surprise